该类中唯一的另一种药是文迪雅（罗格列酮）。FDA没有临床资料将文迪雅与接受该药患者的膀胱癌联系联系起来。
The only other drug in this class is Avandia (rosiglitazone). The FDA has no clinical information associating Avandia with bladder cancer in patients receiving that drug.
目的观察马来酸罗格列酮（商品名文迪雅）与胰岛素合用治疗2型糖尿病（T 2DM）的临床疗效和安全性。
OBJECTIVE To observe the clinical therapeutic effects and safety in the treatment of type 2 diabetes mellitus(T2DM) with Avandia and Insulin.
英国糖尿病协会，正在劝告还在服用文迪雅（罗格列酮）的任何人，毫不犹豫地与保健医生商榷，改换最适合他们需要的治疗。
Diabetes UK is advising anyone currently taking Avandia to consult their healthcare team without delay to discuss switching onto an alternative treatment that is best suited to their needs.
目的探讨马来酸罗格列酮(文迪雅)对2型糖尿病的临床疗效。
Objective To investigate clinical curative effect of rosiglitazone maleate (Avandia) in treating type 2 diabetes.
FDA声明，医疗服务提供者和患者必须纳入文迪雅-罗格列酮药品方问计划，以处方和接收罗格列酮。
"Healthcare providers and patients must be enrolled in the Avandia-Rosiglitazone medicines Access Program in order to prescribe and receive rosiglitazone medicines," the FDA statement says.
凯文·罗格曾经是我的老板。
凯文·罗格曾经是我的老板。
应用推荐